Tonic chemoreflex activation contributes to increased sympathetic nerve activity in heart failure-related anemia

Hypertension

Volumn 55, Issue 4, 2010, Pages 1012-1017

  Franchitto, Nicolas ^a,b,c   Despas, Fabien ^a,b,c   Labrunée, Marc ^a,b,c   Roncalli, Jérome ^c   Boveda, Serge ^d   Galinier, Michel ^c   Senard, Jean Michel ^a,b,c   Pathak, Atul ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d CLINIQUE PASTEUR   (France)

Author keywords

Anemia; Chemoreflex; Chronic heart failure; Microneurography; Sympathetic nerve activity

Indexed keywords

OXYGEN;

ADRENERGIC ACTIVITY; ADULT; ANEMIA; ARTICLE; BLOOD GAS ANALYSIS; BLOOD OXYGEN TENSION; CHEMORECEPTOR; CHEMORECEPTOR REFLEX; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EVIDENCE BASED MEDICINE; FEMALE; HEART FAILURE; HEART HEMODYNAMICS; HUMAN; MALE; NEUROLOGIC EXAMINATION; OXYGEN BREATHING; OXYGEN SATURATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORY NERVE CONDUCTION; SYMPATHETIC FUNCTION; SYMPATHETIC NERVE; ADRENERGIC SYSTEM; AGED; ANALYSIS OF VARIANCE; CROSSOVER PROCEDURE; DRUG EFFECT; ECHOCARDIOGRAPHY; HEART RATE; HEMODYNAMICS; HOSPITALIZATION; INNERVATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; SKELETAL MUSCLE;

AGED; ANALYSIS OF VARIANCE; ANEMIA; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART RATE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OXYGEN; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; SYMPATHETIC NERVOUS SYSTEM;

EID: 77950479728     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.146779     Document Type: Article

References (30)

1. Brunner-La Rocca HP, Esler MD, Jennings GL, Kaye DM. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J. 2001;22:1136-1143.
2. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615-621.
3. Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Bolla G, Mancia G. Effects of hypertension and obesity on the sympathetic activation of heart failure patients. Hypertension. 2003;42:873-877.
4. Despas F, Detis N, Dumonteil N, Labrunee M, Bellon B, Franchitto N, Galinier M, Senard JM, Pathak A. Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activation. J Hypertens. 2009;27:1849-1854.
5. Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer P. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol. 2008;52:818-827.
6. Tang YD, Katz SD. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation. 2006;113: 2454-2461.
7. Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Ghali WA, Knudtson ML; for the APPROACH Investigators. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol. 2004;44:1587-1592.
8. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation. 2004;109:1004-1009.
9. Young JB, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, O'Connor CM, She L, Sun JL, Yancy CW, Fonarow GC; for the OPTIMIZE-HF Investigators and Coordinators. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). Am J Cardiol. 2008;101:223-230.
10. Tang WH, Tong W, Jain A, Francis GS, Harris CM, Young JB. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. J Am Coll Cardiol. 2008;51:569-576.
11. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure: the Prospective Randomized Amlodipine Survival Evaluation (PRAISE). J Am Coll Cardiol. 2003;41:1933-1939.
12. Dec GW. Anemia in heart failure time to rethink its etiology and treatment? J Am Coll Cardiol. 2006;48:2490-2492.
13. Komajda M, Anker SD, Charlesworth A, Okonko D, Metra M, Di Lenarda A, Remme W, Moullet C, Swedberg K, Cleland JG, Poole-Wilson PA. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J. 2006;27: 1440-1446.
14. Sharma R, Francis DP, Pitt B, Poole-Wilson PA, Coats AJ, Anker SD. Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II Trial. Eur Heart J. 2004;25:1021-1028.
15. Sangkatumvong S, Coates TD, Khoo MC. Abnormal autonomic cardiac response to transient hypoxia in sickle cell anemia. Physiol Meas. 2008; 29:655-668.
16. Yokusoglu M, Nevruz O, Baysan O, Uzun M, Demirkol S, Avcu F, Koz C, Cetin T, Hasimi A, Ural AU, Isik E. The altered autonomic nervous system activity in iron deficiency anemia. Tohoku J Exp Med. 2007;212: 397-402.
17. Chua TP, Ponikowski PP, Harrington D, Chambers J, Coats AJ. Contribution of peripheral chemoreceptors to ventilation and the effects of their suppression on exercise tolerance in chronic heart failure. Heart. 1996; 76:483-489.
18. Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympa-thetic control in patients with heart disease. N Engl J Med. 1971;285: 877-883.
19. Lee LY, Pisarri TE. Afferent properties and reflex functions of broncho-pulmonary C-fibers. Respir Physiol. 2001;125:47-65.
20. Ciarka A, Cuylits N, Vachiery JL, Lamotte M, Degaute JP, Naeije R, van de Borne P. Increased peripheral chemoreceptors sensitivity and exercise ventilation in heart transplant recipients. Circulation. 2006;113:252-257.
21. Sun SY, Wang W, Zucker IH, Schultz HD. Enhanced peripheral che-moreflex function in conscious rabbits with pacing-induced heart failure. J Appl Physiol. 1999;86:1264-1272.
22. van de Borne P, Oren R, Anderson EA, Mark AL, Somers VK. Tonic chemoreflex activation does not contribute to elevated muscle sympathetic nerve activity in heart failure. Circulation. 1996;94:1325-1328.
23. Ponikowski P, Chua TP, Anker SD, Francis DP, Doehner W, Banasiak W, Poole-Wilson PA, Piepoli MF, Coats AJ. Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation. 2001;104:544-549.
24. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, Mancini DM. Hemodilution is common in patients with advanced heart failure. Circulation. 2003;107:226-229.
25. Najem B, Unger P, Preumont N, Jansens JL, Houssière A, Pathak A, Xhaet O, Gabriel L, Friart A, De Roy L, Vandenbossche JL, van de Borne P. Sympathetic control after cardiac resynchronization therapy: responders versus nonresponders. Am J Physiol Heart Circ Physiol. 2006;291:H2647-H2652.
26. Kourea K, Parissis JT, Farmakis D, Panou F, Paraskevaidis I, Venetsanou K, Filippatos G, Kremastinos DT. Effects of darbepoetin-α on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure. Atherosclerosis. 2008;199:215-221.
27. Bozkurt B, Mann DL, Deswal A. Biomarkers of inflammation in heart failure. Heart Fail Rev. In press.
28. Miján-de-la-Torre A. Recent insights on chronic heart failure, cachexia and nutrition. Curr Opin Clin Nutr Metab Care. 2009;12:251-257.
29. Guyton AC, Hall JE. Textbook of Medical Physiology. 11th ed. Philadelphia, PA: WB Saunders; 2006.
30. Somers VK, Mark AL, Abboud FM. Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans. J Clin Invest. 1991;87:1953-1957.